Kreske Nickelsen
Chief Executive Officer at Joint Polish Investment Fund Management BV
Network origin in Kreske Nickelsen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Aescap Venture Management BV
 Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector.
5
| Private Company | Investment Managers | 5 |
Joint Polish Investment Fund Management BV
 Joint Polish Investment Fund Management BV Investment ManagersFinance Joint Polish Investment Fund Management BV (Joint Polish Investment Fund Management) is a venture capital firm founded in 2015. The firm headquartered in Netherlands.
4
| Private Company | Investment Managers | 4 |
Phase2 Microtechnologies, Inc.
 Phase2 Microtechnologies, Inc. Electronic ComponentsElectronic Technology Phase2 Microtechnologies, Inc. is a technology development company that offers Micro-Electro-Mechanical Systems-enabled pH sensor technology platforms. The company was founded in 2016 and is headquartered in Pittsburgh, PA.
3
| Holding Company | Electronic Components | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kreske Nickelsen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Essenoids Sp zoo | Chief Executive Officer Corporate Officer/Principal | ||
| AIRWAY MEDIX S.A. | Medical Specialties | Chief Executive Officer Investor Relations Contact | |
| University of Warsaw | College/University | Undergraduate Degree Graduate Degree | |
| Venture Advisor Sp zoo | Director/Board Member Chief Executive Officer | ||
| ADIUVO INVESTMENTS S.A. | Biotechnology | Chief Executive Officer Investor Relations Contact | |
| Adiuvo Management Sp zoo | Director/Board Member Chief Executive Officer | ||
| Warszawski Uniwersytet Medyczny | College/University | Doctorate Degree Doctorate Degree | |
| E-SHOPPING GROUP S.A. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| Glia Sp zoo | Director/Board Member Chief Executive Officer | ||
| Nutra Sp zoo | Chief Executive Officer Corporate Officer/Principal | ||
Orphinic Scientific SA
 Orphinic Scientific SA BiotechnologyHealth Technology Orphinic Scientific engages in the development and delivery of pharmaceutical drugs for the treatments of rare diseases. The firm also provides research and development services. The company was founded by and is headquartered in Rome, Italy. | Biotechnology | Chief Executive Officer | |
| Kozminski University | College/University | Masters Business Admin | |
| The World Bank | Supranational | Corporate Officer/Principal | |
Medicover Sp zoo
 Medicover Sp zoo Hospital/Nursing ManagementHealth Services Medicover Sp zoo operates healthcare facilities. Its offer includes medical services, surgery, dietary advice, vaccinations, and treatment. The company was founded in 1997 and is headquartered in Warsaw, Poland. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
KCR CRO GmbH
 KCR CRO GmbH Miscellaneous Commercial ServicesCommercial Services KCR SA provides clinical research services. It operates as a European contract research organization and strategic solutions provider for companies who are looking for a reliable alternative to global contract research organizations. The firm’s services include clinical trial, functional service provision, and late phase studies. It offers clinical project management, clinical monitoring, site management, feasibility studies, regulatory affairs, site start-up and contracting, biometrics and data management, quality assurance, cross-functional sourcing model, functional sourcing model, post-authorization efficacy study, post-authorization safety study, pricing and market access research, and case control study. The company was founded by Marek Kiecana in 1997 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Pharmaceuticals: Major | Director/Board Member | |
Outrun Therapeutics Ltd.
 Outrun Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Outrun Therapeutics Ltd. is a British biotechnology company founded in 2019 that develops a platform for drug discovery. | Miscellaneous Commercial Services | Director/Board Member | |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Director/Board Member | |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
iOnctura SA
 iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
| Government of Poland | Sovereign | Corporate Officer/Principal | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
| PROGYNY, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| Silicon Fields Sp zoo | Chief Executive Officer | ||
| VIVID GAMES S.A. | Packaged Software | Director/Board Member | |
ScaleThings Sp zoo
 ScaleThings Sp zoo Miscellaneous Commercial ServicesCommercial Services ScaleThings Sp zoo engages in the research in the field of biotechnology. The company was founded by Ronny Barak on January 3, 2014 and is headquartered in Warsaw, Poland. | Miscellaneous Commercial Services | Director/Board Member | |
| Algaelabs Sp zoo | Corporate Officer/Principal | ||
| Peptaderm Sp zoo | Chief Executive Officer | ||
| Biovo Sp zoo | Chief Executive Officer | ||
| Marmar Investment Sp zoo | Chief Executive Officer | ||
| Prodolux Sp zoo | Chief Executive Officer | ||
| Brandmakers Sp zoo | Chief Executive Officer | ||
INKEF Capital BV
 INKEF Capital BV Investment ManagersFinance INKEF Capital BV is an Independent Venture Capital firm founded in 2010 by Frank R Landsberger. INKEF Capital BV is headquartered in Amsterdam. | Investment Managers | Director of Finance/CFO | |
| Vacore Sp zoo | Chief Executive Officer | ||
| Ip Alley Sp zoo | Chief Executive Officer | ||
| Diabene Sp zoo | Chief Executive Officer | ||
| Immd Health Sp zoo | Chairman | ||
| Endo Sp zoo | Chairman | ||
| Endo Medical Sp zoo | Chief Executive Officer | ||
| Polish Peptide Laboratory Sp zoo | Chief Executive Officer | ||
| Ibinkubator Sp zoo | Chairman | ||
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| Poland | 35 |
| United States | 5 |
| United Kingdom | 5 |
| Germany | 3 |
| Netherlands | 3 |
Sectoral
| Health Technology | 12 |
| Commercial Services | 8 |
| Consumer Services | 4 |
| Government | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 44 |
| Chief Executive Officer | 27 |
| Private Equity Investor | 10 |
| Corporate Officer/Principal | 9 |
| Chairman | 7 |
Most connected contacts
- Stock Market
- Insiders
- Kreske Nickelsen
- Company connections
